OptimizeRx appoints Brendan Merrell COO; expands Stelmakh, Odence-Ford, D'Silva roles

OptimizeRx Corp

Brendan Merrell named COO effective Aug 18, 2025; base salary $325k, target bonus 40%.
Ed Stelmakh becomes Chief Financial & Strategic Officer, adding corporate strategy to finance duties.
Marion Odence-Ford promoted to Chief Legal & Administrative Officer, adding admin oversight.
Andy D'Silva promoted to Chief Business Officer, leading FP&A, IR, and strategic planning.
Changes designed to accelerate Rule of 40 strategy (sustained growth + profitability) over 2-3 years.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.